Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2025-08-22 Regulatory Filings
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. The document length is only 898 characters, indicating it is a brief regulatory announcement rather than a detailed report. There are no financial statements, management discussion, or other report content. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-08-22 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as approval dates, shareholder meeting resolution date, and regulatory approval references. There is no financial data, no report attached or referenced as being published, and no mention of financial results or management changes. This is a regulatory announcement about a corporate name change, which does not fit into financial reports or management changes categories. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-08-21 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) regarding a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and no detailed analysis or presentation. The document is a regulatory announcement about a corporate action (name change) rather than a financial report or detailed management information. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-08-20 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」， 公告期間：114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory announcement about a corporate name change, which does not fit into financial reports or detailed filings. It is best classified as a Regulatory Filing (RNS) as a general announcement that does not fit other categories.
2025-08-19 Chinese
代子公司「中國化學製藥股份有限公司」及 「中化裕民健康事業股份有限公司」公告主辦會計異動
Board/Management Information Classification · 95% confidence The document is a short announcement (793 characters) about a personnel change specifically regarding the chief accountant of subsidiaries of the company 3716 中化控股. It details the resignation of the previous chief accountant and the temporary appointment of a new one, with a note that the formal appointment will be announced after board approval. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management or board members. The document is not a full report, nor an earnings release or audit report. Therefore, the classification is MANG with high confidence.
2025-08-18 Chinese
公告本公司會計主管異動
Board/Management Information Classification · 95% confidence The document is a short announcement regarding a change in the company's accounting supervisor, including details about the resignation and temporary replacement. It does not contain financial data, report content, or detailed management discussion. It is an announcement of a management personnel change, specifically about a key financial officer. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on personnel change, confirming this classification.
2025-08-18 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.